Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control study.
Viktor GrutMartin BiströmJonatan SalzerPernilla StridhDaniel JonsRasmus GustafssonAnna Fogdell-HahnJesse HuangNicole BrennerJulia ButtNoemi BenderAnna LindamLucia Alonso-MagdalenaMartin GunnarssonMagnus VrethemTomas BergströmOluf AndersenIngrid KockumTim WaterboerTomas OlssonPeter SundströmPublished in: European journal of neurology (2021)
Cytomegalovirus seropositivity is associated with a decreased risk for MS. The protective role for CMV infection in MS aetiology is further supported by the interactions between CMV seronegativity and EBV and HHV-6A seropositivity.